Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...
Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...
LeAnn Rimes undergoes $10,000 plasma exchange treatment to remove "micro-toxins" from her body. The country star shares her ...
Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...
LeAnn Rimes is starting 2026 by putting her body front and center after what she described as an exhausting stretch ...
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
Data suggest that remote patient monitoring may support outpatient step-up dosing of bispecific antibodies by enabling earlier CRS detection.
BioCryst Pharmaceuticals is a Hold, as ORLADEYO faces mounting competitive pressures and the company pivots toward ...
NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most sign ...
Zacks Investment Research on MSN
Is BMY's deep pipeline the key to its next growth phase?
Bristol Myers Squibb BMY highlighted the potential of its deep and promising pipeline at the 44th Annual J.P. Morgan Healthcare Conference, held earlier this month. Key pipeline candidates in BMY’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback